CI

Cisterna Biologics

YC S22

San Diego, US · Founded 2022 · 2 employees · 1 known investors

cisternabx.com ↗

Cisterna Biologics develops yeast-engineered mRNA manufacturing technology that can be selectively purified to drive protein expression in human cells. The company targets cost-effective, scalable, and non-immunogenic mRNA production for therapeutic applications.

Founders & leadership· Y Combinator alumni (S22)

Hari BhaskaraninFounder

Investors · 1

Y

Y CombinatorMountain View · $500K – $500K